# Peter R. Galle

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-r-galle/

## Facts

| Field | Value |
| --- | --- |
| Citations | 108,764 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 127 |
| i10-index | 763 |
| Last Known Institution | Johannes Gutenberg University Mainz |
| OpenAlex ID | https://openalex.org/A5069151214 |
| ORCID iD | https://orcid.org/0000-0001-8294-0992 |
| Works | 2,314 |

## Researcher papers

- [Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-after-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma/)
- [Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo](https://scholariq.org/papers/blockade-of-interleukin-6-trans-signaling-suppresses-t-cell-resistance-against/)
- [Colorectal cancer](https://scholariq.org/papers/colorectal-cancer-2/)
- [Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening](https://scholariq.org/papers/elafibranor-an-agonist-of-the-peroxisome-proliferator-activated-receptor-and/)
- [Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis](https://scholariq.org/papers/methylene-blue-aided-chromoendoscopy-for-the-detection-of-intraepithelial/)
- [CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes](https://scholariq.org/papers/cd28-dependent-rac1-activation-is-the-molecular-target-of-azathioprine-in/)
- [EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma](https://scholariq.org/papers/easl-clinical-practice-guidelines-on-the-management-of-hepatocellular-carcinoma/)
- [Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-versus-lenvatinib-plus-placebo-for-advanced/)
- [Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma](https://scholariq.org/papers/four-year-overall-survival-update-from-the-phase-iii-himalaya-study-of/)
- [Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients](https://scholariq.org/papers/role-of-the-galad-and-balad-2-serologic-models-in-diagnosis-of-hepatocellular/)
- [Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells](https://scholariq.org/papers/sorafenib-perpetuates-cellular-anticancer-effector-functions-by-modulating-the/)
- [Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study](https://scholariq.org/papers/development-validation-and-prognostic-evaluation-of-a-risk-score-for-long-term/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)

## Researcher university

- [Johannes Gutenberg University Mainz](https://scholariq.org/institutions/johannes-gutenberg-university-mainz/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.